BMC
MIRM icon

Bear Mountain Capital’s Mirum Pharmaceuticals MIRM Stock Holding History

Bear Mountain Capital’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-100
Closed -$2.38K – 204
2024
Q1 		$2.38K Hold
100
– – ﹤0.01% 163
2023
Q4 		$2.67K Buy
+100
New +$3.03K ﹤0.01% 166

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bear Mountain Capital's MIRM Position: Q2 2024 in Review

Bear Mountain Capital sold out of Mirum Pharmaceuticals (MIRM) in Q2 2024, closing a stake of 100 shares — an estimated $2.38K sold.

Bear Mountain Capital first reported a position in MIRM in Q4 2023 and held it in 2 quarters. The position peaked at $2.67K in Q4 2023. 160 funds tracked by Wall St. Rank hold MIRM as of Q2 2024.

  • Bear Mountain Capital reported no remaining Mirum Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Bear Mountain Capital sold 100 Mirum Pharmaceuticals shares in Q2 2024, an estimated $2.38K.
  • Bear Mountain Capital first reported a position in Mirum Pharmaceuticals in Q4 2023 and held it in 2 quarters.
  • Bear Mountain Capital's Mirum Pharmaceuticals position peaked at $2.67K in Q4 2023.
  • 160 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2024.

Based on Bear Mountain Capital's 13F filing for Q2 2024, filed 23 Jul 2024.